Staff from specialist inhaler firm Vectura have been barred from attending a pharmaceutical industry conference days after its controversial £1.1bn acquisition by tobacco group Philip Morris International (PMI). In an apparent rebuff by academics over the deal, Vectura was stripped of its sponsorship of a major lung health conference due to take place this...